23.02.2017 RHÖN-KLINIKUM AG  DE0007042301

DGAP-News: RHÖN-KLINIKUM AG: RHÖN-KLINIKUM AG Reduces Size of Management Board


 
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Change of Personnel/Miscellaneous RHÖN-KLINIKUM AG: RHÖN-KLINIKUM AG Reduces Size of Management Board 23.02.2017 / 12:59 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- RHÖN-KLINIKUM AG Reduces Size of Management Board - Martin Menger and Jens-Peter Neumann to leave management board - Adjusted departmental responsibilities Bad Neustadt / Saale, 23rd February 2017 The supervisory board of RHÖN-KLINIKUM AG has decided to reduce the size of the management board from five to three members by revoking the appointment of Martin Menger (operative business) and Jens-Peter Neumann (finance) to the management board. The management board of the company therefore consists of Mr. Stephan Holzinger (chairman), Dr. Dr. Martin Siebert (deputy chairman) and Prof. Dr. Bernd Griewing. The responsibilities within the management board have been adjusted accordingly. Stephan Holzinger is now responsible for corporate strategy, the group divisions of corporate communication, IT/artificial intelligence, investor relations and finance, taxes & controlling and the departments of internal revision, compliance and group headquarters. He is also responsible for the university hospitals in Giessen and Marburg. As deputy chairman Dr. Dr. Siebert is responsible for the group divisions of materials management, service & logistics, building & technology, personnel & salaries as well as the specialist area of law and also for group data protection. He is also responsible for the hospitals in Bad Berka and Frankfurt/Oder. As well as being responsible for the Medical Board Prof. Dr. Bernd Griewing will also be responsible for the group divisions of patient safety, quality management & hygiene, medical process management and the specialist area of network medicine & innovations. Furthermore he will be responsible for Rhön Innovations GmbH and the Bad Neustadt site and therefore our first campus project to be realised. "The company thanks Martin Menger for his service of sixteen years, including his work on the management board since 2011. He stands for a large number of our hospital acquisitions and their successful integration into our corporate group and he also played a very significant role in steadying the hospitals in Giessen and Marburg in a demanding environment. Mr. Neumann worked successfully on the Fresenius/Helios transaction and handled RHÖN-Innovations GmbH and also contributed to the future corporate strategy," CEO Stephan Holzinger stated. ************************************************************************** RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. At five medical sites with a total of 5,300 beds we offer cutting-edge medical care with a direct link to universities and research institutes. Our top five key areas of treatment are cardiological and coronary disease, neurological disorders, oncology, lung diseases as well as orthopedic and accident surgery. A total of around 16,000 employees work for RHÖN-KLINIKUM AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. Further information is available at: www.rhoen-klinikum-ag.com. Your Contact Persons: RHÖN-KLINIKUM AG Achim Struchholz Group Division Head of Corporate Communication Schlossplatz 1 97616 Bad Neustadt / Saale Telephone: + 49 - 9771 65-1327 Facsimile: + 49 - 9771 65-1820 E-mail: [email protected] Dr. Kai G. Klinger Investor Relations & Corporate Finance Schlossplatz 1 97616 Bad Neustadt / Saale Telephone: + 49 - 9771 65-1318 Facsimile: + 49 - 9771 99-1736 E-mail: [email protected] --------------------------------------------------------------------------- 23.02.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 547183 23.02.2017


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.510,00
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 107,50
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 41,00
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,72
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 35,00
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,32
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 0,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,51
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 11,000 Halten 736,59
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
15,28 27,78 0,55 18,97
KBV KCV KUV EV/EBITDA
0,60 17,84 0,51 7,66
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,15 1,36 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 09.11.2023 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,83% -2,37% 10,00% -12,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK